The study of efficacy and safety of tamsulosin in therapy of stent-related symptoms has demonstrated that tamsulosin relieves stent-related irritative symptoms and improves quality of life. Further prospective trials are needed to finally assess tamsulosin efficacy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[tamsulosin administration
4
administration prophylaxis
4
prophylaxis treatment
4
treatment stent-related
4
stent-related symptoms]
4
symptoms] study
4
study efficacy
4
efficacy safety
4
safety tamsulosin
4
tamsulosin therapy
4

Similar Publications

Guillain-Barré Syndrome (GBS) is an acute inflammatory polyradiculoneuropathy that affects the peripheral nervous system, predominantly impairing motor function. Pain, both somatic and neuropathic, is reported in 89% of cases and is refractory to first-line analgesics in most of these. We present the case of a 75-year-old woman with an acute presentation of areflexic flaccid tetraparesis compatible with GBS.

View Article and Find Full Text PDF

Background: Dementia is a global public health challenge. Certain medications, such as anticholinergics and benzodiazepines, have been linked to an increased dementia risk. However, most studies focused on a limited range of drugs, lacking a comprehensive overview.

View Article and Find Full Text PDF

Introduction: Despite all the achievements of modern medicine, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) remains a difficult disorder to treat. Patients are often dissatisfied with the treatment outcomes, since the main symptoms, namely pain and urination disorders, usually decrease, but do not completely resolve.

Aim: To study the efficiency of the combined drug Prostatex Plus in the treatment of patients with CPPS (IIIb).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how chronic treatment with tamsulosin, used for benign prostatic hyperplasia (BPH), impacts the eye during cataract surgery, particularly focusing on Intraoperative Floppy Iris Syndrome (IFIS).
  • It involved 100 male patients, with 24 using BPH medication, revealing that mydriasis management was necessary in many cases, and some complications arose during surgery, like iris damage.
  • The findings suggest that stopping tamsulosin shortly before surgery may not prevent IFIS, indicating that patients who may develop cataracts should consult an ophthalmologist early on.
View Article and Find Full Text PDF

Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease-a prospective pilot study.

Eye (Lond)

January 2025

The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Background: Sympathetic overstimulation of Müller's muscle is a suggested mechanism underlying upper eyelid retraction in thyroid eye disease (TED). We examined the effect of tamsulosin, an alpha-1 antagonist, on eyelid retraction in patients with TED.

Methods: A single-centre prospective study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!